Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $763.78 million. The enterprise value is $532.57 million.
| Market Cap | 763.78M |
| Enterprise Value | 532.57M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 130.78 million shares outstanding. The number of shares has increased by 0.94% in one year.
| Current Share Class | 130.78M |
| Shares Outstanding | 130.78M |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 8.43% |
| Owned by Institutions (%) | 52.16% |
| Float | 105.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.67 |
| Forward PS | 3.49 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.46 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -598.46 |
Financial Efficiency
Return on equity (ROE) is -23.20% and return on invested capital (ROIC) is -52.88%.
| Return on Equity (ROE) | -23.20% |
| Return on Assets (ROA) | -6.20% |
| Return on Invested Capital (ROIC) | -52.88% |
| Return on Capital Employed (ROCE) | -12.92% |
| Weighted Average Cost of Capital (WACC) | 10.18% |
| Revenue Per Employee | $295,370 |
| Profits Per Employee | -$115,501 |
| Employee Count | 703 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, CTKB has paid $41.24 million in taxes.
| Income Tax | 41.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.41% in the last 52 weeks. The beta is 1.14, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +21.41% |
| 50-Day Moving Average | 5.50 |
| 200-Day Moving Average | 4.68 |
| Relative Strength Index (RSI) | 53.14 |
| Average Volume (20 Days) | 1,261,220 |
Short Selling Information
The latest short interest is 4.11 million, so 3.14% of the outstanding shares have been sold short.
| Short Interest | 4.11M |
| Short Previous Month | 4.41M |
| Short % of Shares Out | 3.14% |
| Short % of Float | 3.88% |
| Short Ratio (days to cover) | 2.90 |
Income Statement
In the last 12 months, CTKB had revenue of $207.65 million and -$81.20 million in losses. Loss per share was -$0.63.
| Revenue | 207.65M |
| Gross Profit | 110.89M |
| Operating Income | -46.68M |
| Pretax Income | -39.96M |
| Net Income | -81.20M |
| EBITDA | -38.80M |
| EBIT | -46.68M |
| Loss Per Share | -$0.63 |
Balance Sheet
The company has $255.90 million in cash and $24.69 million in debt, with a net cash position of $231.21 million or $1.77 per share.
| Cash & Cash Equivalents | 255.90M |
| Total Debt | 24.69M |
| Net Cash | 231.21M |
| Net Cash Per Share | $1.77 |
| Equity (Book Value) | 321.35M |
| Book Value Per Share | 2.46 |
| Working Capital | 293.98M |
Cash Flow
In the last 12 months, operating cash flow was -$6.59 million and capital expenditures -$6.89 million, giving a free cash flow of -$13.48 million.
| Operating Cash Flow | -6.59M |
| Capital Expenditures | -6.89M |
| Depreciation & Amortization | 7.88M |
| Net Borrowing | -202,000 |
| Free Cash Flow | -13.48M |
| FCF Per Share | -$0.10 |
Margins
Gross margin is 53.40%, with operating and profit margins of -22.48% and -39.10%.
| Gross Margin | 53.40% |
| Operating Margin | -22.48% |
| Pretax Margin | -19.24% |
| Profit Margin | -39.10% |
| EBITDA Margin | -18.68% |
| EBIT Margin | -22.48% |
| FCF Margin | n/a |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.94% |
| Shareholder Yield | -0.94% |
| Earnings Yield | -10.76% |
| FCF Yield | -1.77% |
Analyst Forecast
The average price target for CTKB is $6.50, which is 11.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.50 |
| Price Target Difference | 11.30% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 6.55% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 3.32 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 3 |